Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia

Leukemia Research

Volumn 22, Issue 6, 1998, Pages 527-535

  Fontenay Roupie, Michaëla ^a   Dupont, Jean Michel ^b   Picard, Françoise ^a   Fichelson, Serge ^c   Botella, Anne ^a   Melle, Josiane ^a   Guesnu, Martine ^a   Casadevall, Nicole ^d   Dreyfus, François ^a   Bouscary, Didier ^a  

^a INSTITUT COCHIN   (France)

^b Hop Cochin 27 R Du Faubourg S   (France)

^c Hop Raymond Poincare Garches ^*  (France)

^d Laboratoire d'Hématologie   (France)

Author keywords

c MPL; Fluorescence in situ hybridization; Hematopoietic progenitors; Megakaryocyte growth and development factor; Myelodysplasia; Thrombopoietin

Indexed keywords

MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; THROMBOPOIETIN;

ARTICLE; BLAST CELL; BONE MARROW CELL; CELL GROWTH; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MONONUCLEAR CELL; MYELODYSPLASIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; UNSCHEDULED DNA SYNTHESIS;

BLAST CRISIS; BLOTTING, NORTHERN; CELL CULTURE TECHNIQUES; CELL DIVISION; CLONE CELLS; COLONY-FORMING UNITS ASSAY; DNA; HEMATOPOIETIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MEGAKARYOCYTES; METHYLCELLULOSE; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, THROMBOPOIETIN; RECOMBINANT PROTEINS; RNA; THROMBOPOIETIN;

EID: 19244377909     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00028-9     Document Type: Article

References (32)

1. Koeffler H.P. Myelodysplastic syndromes (preleukemia). Semin Hematol. 53:1986;284.
2. Janssen J.W.G., Buschle M., Layton M., Drexler H.G., Lyons J., van den Berghe H., Heimpel H., Kubanek B., Kleihauer E., Mufti G.J., Bartram C.R. Clonal evidence of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood. 73:1989;248.
3. Greenberg P.L. Biological and clinical implications of marrow culture studies in the myelodysplastic syndromes. Semin Hematol. 33:1996;163.
4. Merchav S., Nielsen O.J., Rosenbaum H. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. Leukemia. 4:1990;771.
5. Nagler A., Mackichan M.L., Negrin R. Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: comparison between recombinant human granulocyte colony stimulative factor (CSF) and recombinant human granulocyte-monocyte CSF. Blood. 76:1990;1299.
6. Sawada K., Sato N., Notoya A., Tarumi T., Hirayama S., Takano H., Koizumi K., Yasukouchi T., Yamaguchi M., Koike T. Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells. Blood. 85:1995;194.
7. Backx B., Broeders L., Löwenberg B. Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome. Blood. 80:1992;1213.
8. Glinsmann-Gibson B., Spier C., Baire M.et al. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndromes. Leukemia. 8:1994;827.
9. de Sauvage F.J., Hass P.E., Spencer S.D., Malloy B.E., Gurney A.L., Spencer S.A., Darbonne W.C., Henzel W.J., Wong S.C., Kuang W.-J., Oles K.J., Hultgren B., Solberg L.A., Goeddel D.V., Eaton D.L. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-MPL ligand. Nature. 369:1994;533.
10. Lok S., Kaushansky K., Holly R.D., Kuijper J.L., Lofton-Day C.E., Oort P.J., Grant F.J., Heipel M.D., Burkhead S.K., Kramer J.M., Bell L.A., Sprecher C.A., Blumberg H., Johnson R., Prunkard D., Ching A.F.T., Mathewes S.L., Bailey M.C., Forstrom J.W., Buddle M.M., Osborn S.G., Evans S.J., Sheppard P.O., Presnell S.R., O'Hara P.J., Hagen F.S., Roth G.J., Forster D.C. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 369:1994;565.
11. Wendling F., Maraskovsky E., Debili N., Florindo C., Teepe M., Titeux M., Methia N., Breton-Gorius J., Cosman D., Vainchenker W. c-MPL ligand is a humoral regulator of megakaryocytopoiesis. Nature. 369:1994;571.
12. Matsumura I., Kanakura Y., Kato T., Ikeda H., Ishikawa J., Horikawa Y., Hashimoto K., Moroyama Y., Tsujimura T., Nishiura T., Miyazaki H., Matsuzawa Y. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood. 86:1995;703.
13. Quentmeier H., Zaborski M., Graf G., Ludwig W.D., Drexler H.G. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cell lines. Leukemia. 10:1996;297.
14. Drexler H.G., Quentmeier H. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells. Leukemia. 10:1996;1405.
15. Vigon I., Dreyfus F., Melle J., Viguié F., Ribrag V., Cocault L., Souyri M., Gisselbrecht S. Expression of the c-MPL proto-oncogene in human hematologic malignancies. Blood. 82:1993;877.
16. Bouscary D., Preudhomme C., Ribrag V., Melle J., Viguié F., Picard F., Guesnu M., Fenaux P., Gisselbrecht S., Dreyfus F. Prognostic value of c-MPL expression in myelodysplastic syndromes. Leukemia. 9:1995;783.
17. Bennett J.M., Catovsky D., Flandrin G., Daniel M.T., Galton D.A.G., Gralnick H., Sultan C. Proposal for the classification of the myelodysplastic syndromes. Br J Haematol. 51:1982;189.
18. Debili N., Wendling F., Cosman D., Titeux M., Florindo C., Dusanter-Fourt I., Schooley K., Methia N., Charon M., Nador R., Bettaieb A., Vainchenker W. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood. 85:1995;391.
19. Sawada K., Ieko M., Notoya A., Tarumi T., Koizumi S., Kitayama S., Nishio H., Fukada Y., Yasukouchi T., Yamaguchi M., Katoh S., Koike T. Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells. Blood. 88:1996;319.
20. Dupont JM, Fontenay-Roupie M, Fichelson S, Dupuy O, Lebarr A, Le Tessier D, Auvinet P, Rabineau D. Fluorescence in situ hybridization (FISH) on methylcellulose cultured hematopoietic stem cells from myelodysplastic syndromes. Cancer Genet Cytogenet (in press).
21. Archimbaud E., Ottman O., Liu Yin J.A., Lechner K., Dombret H., Sanz M.A., Herrman F., Gruss H., Fenaux P., Ganser A., Heil G., Kanz L., Brugger W., Sims T., Olsen K., Hoelzer D. A randomised, double-blind, placebo-controlled study using PEG-rHuMGDF as an adjunct to chemotherapy for adults with de-novo acute myeloid leukaemia (AML): early results. Blood Abstr. Suppl 1:1996;447a.
22. Löwenberg B., van Putten W.L.J., Touw I.P., Delwel R., Santini V. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. New Engl J Med. 328:1993;614.
23. Verma D.S., Spitzer G., Dicke K.A., Smith T., McCredie K.B. In vitro agar culture patterns in preleukemia and their clinical significance. Leuk Res. 3:1979;41.
24. Matsumura I., Kanakura Y., Ikeda H., Ishikawa J., Yoshida H., Horikawa Y., Nishiura T., Tahara T., Kato T., Miyazaki H., Matsuzawa Y. Coexpression of thrombopoietin and c-MPL genes in human acute myeloblastic leukemia cells. Leukemia. 10:1996;91.
25. Zeigler F.C., de Sauvage F., Widmer H.R., Keller G.A., Donahue C., Schreiber R.D., Malloy B., Hass P., Eaton D., Matthews W. In vitro megakaryocytopoietic and thrombopoietic activity of c-MPL ligand (TPO) on purified murine hematopoietic stem cells. Blood. 84:1994;4045.
26. Kaushansky K., Broudy V.C., Grossman A., Humes J., Lin N., Ren H.P., Bailey M.C., Papyannopoulou T., Forstrom J.W., Sprugel K.H. Thrombopoietin expands erythroid progenitors, increases red cell production and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest. 96:1995;1683.
27. Kaushansky K., Broudy V.C., Lin N., Jorgensen M.J., McCarty J., Fox N., Zucker-Franklin D., Lofton-Day C. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA. 92:1995;3234.
28. Kobayashi M., Laver J.H., Kato T., Miyazaki H., Ogawa M. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood. 88:1996;429.
29. Juvonen E., Partanen S., Knuutila S., Ruutu T. Megakaryocyte colony formation by bone marrow progenitors in myelodysplastic syndromes. Br J Haematol. 63:1986;331.
30. Juvonen E., Partanen S., Knuutila S., Ruutu T. Colony formation by megakaryocyte progenitors in myelodysplastic syndromes. Eur J Haematol. 42:1989;389.
31. Geissler D., Zwierzina H., Pechlaner C., Gaggl S., Schmalzl L., Konwalinka G., Braunsteiner H. Abnormal megakaryopoiesis in patients with myelodysplastic syndromes: analysis of cellular and humoral defects. Br J Haematol. 73:1989;29.
32. Dan K., An E., Futaki M., Inokuchi K., Gomi S., Yamada T., Ogata K., Tanabe Y., Ohki I., Shinohara T. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Acta Haematol. 89:1993;113.